|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$2.53 |
$2.90 |
$2.46 |
$2.67 |
145.70K | 03/25/2024 |
$2.70 |
$2.75 |
$2.48 |
$2.56 |
37.40K | 03/26/2024 |
$2.53 |
$2.71 |
$2.53 |
$2.71 |
34.40K | 03/27/2024 |
$2.80 |
$2.84 |
$2.73 |
$2.81 |
36.50K | 03/28/2024 |
$2.80 |
$2.94 |
$2.80 |
$2.89 |
15.80K |
|
Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma. | |
|
Genetic Technologies (GENE) has the following price history information. Looking back at GENE historical stock prices for the last five trading days, on March 22, 2024, GENE opened at $2.53, traded as high as $2.90 and as low as $2.46, and closed at $2.67. Trading volume was a total of 145.70K shares. On March 25, 2024, GENE opened at $2.70, traded as high as $2.75 and as low as $2.48, and closed at $2.56. Trading volume was a total of 37.40K shares. On March 26, 2024, GENE opened at $2.53, traded as high as $2.71 and as low as $2.53, and closed at $2.71. Trading volume was a total of 34.40K shares. On March 27, 2024, GENE opened at $2.80, traded as high as $2.84 and as low as $2.73, and closed at $2.81. Trading volume was a total of 36.50K shares. On March 28, 2024, GENE opened at $2.80, traded as high as $2.94 and as low as $2.80, and closed at $2.89. Trading volume was a total of 15.80K shares.
GENE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genetic Technologies shares, starting with a $10,000 purchase of GENE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$142.00 |
|
End price/share: |
$2.89 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.96% |
|
Average Annual Total Return: |
-32.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$203.66 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $2.67 | 03/25/2024 | $2.56 | 03/26/2024 | $2.71 | 03/27/2024 | $2.81 | 03/28/2024 | $2.89 |
|
|